MRK - Merck & Co., Inc.
Close
99.24
0.105 0.106%
Share volume: 114,233
Last Updated: Tue 31 Dec 2024 08:30:14 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.70%
PREVIOUS CLOSE
CHG
CHG%
$99.14
0.10
0.11%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-05 | 2023-08-07 | 2023-11-03 | 2024-02-26 | 2024-05-03 | |
| Total revenue | 14.487 B | 15.035 B | 15.962 B | 14.631 B | 15.775 B | |
| Cost of revenue | 3.926 B | 4.024 B | 4.264 B | 3.912 B | 3.540 B | |
| Gross profit | 10.561 B | 11.011 B | 11.698 B | 10.719 B | 12.235 B | |
| 4.26% | 6.24% | -8.37% | 14.14% | |||
| Operating expenses | 6.755 B | 16.023 B | 5.826 B | 12.431 B | 6.475 B | |
| Selling general and admin | 2.479 B | 2.702 B | 2.519 B | 2.804 B | 2.483 B | |
| Research and development | 4.276 B | 13.321 B | 3.307 B | 9.627 B | 3.992 B | |
| Total expenses | 10.681 B | 20.047 B | 10.090 B | 16.343 B | 10.015 B | |
| 87.69% | -49.67% | 61.97% | -38.72% | |||
| Operating income | 3.806 B | -5.012 B | 5.872 B | -1.712 B | 5.760 B | |
| Ebit | 3.806 B | -5.012 B | 5.872 B | -1.712 B | 5.760 B | |
| Pretax income | 3.650 B | -5.335 B | 5.620 B | -2.046 B | 5.670 B | |
| -246.16% | -205.34% | -136.41% | -377.13% | |||
| Income tax | 825.000 M | 637.000 M | 870.000 M | -820.000 M | 903.000 M | |
| Net income basic | 2.821 B | -5.975 B | 4.745 B | -1.226 B | 4.762 B | |
| -311.80% | 179.41% | -125.84% | 488.42% | |||
| Net income | 2.821 B | -5.975 B | 4.745 B | -1.226 B | 4.762 B | |
| -311.80% | 179.41% | -125.84% | 488.42% |